Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inactivation of the histone H3 K36 methyltransferase NSD1 confers resistance to EZH2 inhibition [ChIP-Seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Inactivation of the histone H3 K36 methyltransferase NSD1 confers resistance to EZH2 inhibition
PubMed Full text in PMC Similar studies
Inactivation of the histone H3 K36 methyltransferase NSD1 confers resistance to EZH2 inhibition [RNA-Seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters [RNA-Seq]
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters [Hi-C]
SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters [ChIP-Seq]
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2]
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [ChIP-seq]
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq]
Three different in vivo models of synovial sarcoma (xenograft: Fuji; PDX: CTG-0331 and CTG-0771) treated with or without the indicated dose of the EZH2 inhibitor, tazemetostat
Targeting Dependency on a Paralog Pair of CBP/p300 against De-repression of KREMEN2 in SMARCB1-Deficient Cancers
PubMed Full text in PMC Similar studies Analyze with GEO2R
Epigenetic antagonism between Snf5 and Ezh2 during oncogenic transformation and elevated levels of H3K27me3 in Snf5-deficient cells
Elevated levels of H3K27me3 in Snf5-deficient cells
Epigenetic antagonism between Snf5 and Ezh2 during oncogenic transformation
Epigenetic pattern after EZH1,2 inhibition in lymohoma cells
PubMed Similar studies
Expression analysis after EZH1,2 inhibition in lymohoma cells
PubMed Similar studies Analyze with GEO2R
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation [cell line_RNA-seq]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on